N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection

Vaccine

Volumn 27, Issue 50, 2009, Pages 7073-7079

  Hill, Jim ^a   Leary, Sophie ^a   Smither, Sophie ^a   Best, Angus ^a   Pettersson, Jonas ^b   Forsberg, Ake ^b   Lingard, Bry ^a   Lipka, Alexandria ^c   Brown, Katherine A ^c   Williamson, E Diane ^a   Titball, Richard W ^d  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

^c Centre for Molecular Microbiology and Infection   (United Kingdom)

^d UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Monoclonal antibody; Plague; Protection

Indexed keywords

BACTERIAL ANTIGEN; LCRV ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 7.3; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHEMICAL MUTAGENESIS; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; YERSINIA PESTIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGENS, BACTERIAL; CELL LINE; EPITOPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; YERSINIA PESTIS;

EID: 70350568777     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.061     Document Type: Article

References (34)

1. Brubaker R.R. Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev 4 (1991) 309-324
2. Achtman M., Morelli G., Zhu P., Wirth T., Diehl I., Kusecek B., et al. Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci USA 101 (2004) 17837-17842
3. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62 (1998) 1315-1352
4. Cornelis G.R. The type III secretion injectisome. Nat Rev Microbiol 4 (2006) 811-825
5. Cornelis G.R., and Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 23 (1997) 861-867
6. Matson J.S., and Nilles M.L. LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis. J Bacteriol 183 (2001) 5082-5091
7. Derewenda U., Mateja A., Devedjiev Y., Routzahn K.M., Evdokimov A.G., Derewenda Z.S., et al. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12 (2004) 301-306
8. Lawton D.G., Longstaff C., Wallace B.A., Hill J., Leary S.E.C., Titball R.W., et al. Interactions of the type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domains. J Biol Chem 277 (2002) 38714-38722
9. Pettersson J., Holmström A., Hill J., Leary S., Frithz-Lindsten E., von Euler-Matell A., et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32 (1999) 961-976
10. Mueller C.A., Broz P., Müller S.A., Ringler P., Erne-Brand F., Sorg I., et al. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310 (2005) 674-676
11. Rosqvist R., Magnusson K.E., and Wolf-Watz H. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J 13 (1994) 964-972
12. Sory M.P., and Cornelis G.R. Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol 14 (1994) 583-594
13. Hakansson S., Schesser K., Persson C., Galyov E.E., Rosqvist R., Homble F., et al. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell membrane and displays a contact-dependent membrane disrupting activity. EMBO J 15 (1996) 5812-5823
14. Wattiau P., Bernier B., Deslee P., Michiels T., and Cornelis G.R. Individual chaperones required for Yop secretion by Yersinia. PNAS 91 (1994) 10493-10497
15. Reithmeier-Rost D., Hill J., Williamson E.D., Elvin S.J., Dittmann S., Wilharm G.G., et al. The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis. Microb Dis 9 (2007) 997-1002
16. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., and Titball R.W. Active immunisation with V-antigen from Yersinia pestis protects against plague. Infect Immun 63 (1995) 2854-2858
17. Heath D.G., Anderson Jr. G.W., Mauro J.M., Welkos S.L., Andrews G.P., Adamovicz J., et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16 (1998) 1131-1137
18. Jones S.M., Day F., Stagg A.J., and Williamson E.D. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 19 (2001) 358-366
19. Williamson E.D., Vesey P.M., Gillhespy K.J., Eley S.M., Green M., and Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol 116 (1999) 107-114
20. Green M., Rogers D., Russell P., Stagg A.J., Bell D.L., Eley S.M., et al. The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol Med Microbiol 23 (1999) 107-113
21. Roggenkamp A., Geiger A.M., Leitritz L., Kessler A., and Heesemann J. Passive immunity to infection with Yersinia spp mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 65 (1997) 446-451
22. Motin V.L., Nakajima R., Smirnov G.B., and Brubaker R.R. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V fusion peptide. Infect Immun 62 (1994) 4192-4201
23. Hill J., Eyles J.E., Elvin S.J., Healey G.D., Lukaszewski R.A., and Titball R.W. Administration of antibody to the lung protects mice against pneumonic plague. Infect Immun 74 (2006) 3068-3070
24. Cowan C., Philipovskiy A.V., Wulff-Strobel C.R., Ye Z., and Straley S.C. Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect Immun 73 (2005) 6127-6137
25. Goure J., Broz P., Attree O., Cornelis G.R., and Attree I. Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J Infect Dis 192 (2005) 218-225
26. Schmidt A., Schaffelhofer S., Müller K., Röllinghoff M., and Beuscher H.U. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity. Microb Pathog 26 (1999) 221-233
27. Sing A., Reithmeier-Rost D., Granfors K., Hill J., Roggenkamp A., and Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci USA 102 (2005) 16049-16054
28. Hill J., Leary S.E.C., Griffin K.F., Williamson E.D., and Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 65 (1997) 4476-4482
29. Weeks S., Hill J., Friedlander A., and Welkos S. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb Pathog 32 (2002) 227-237
30. Carr S., Leary S.E.C., Miller J., Bennett A., Ho A., and Williamson E.D. Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems. Vaccine 18 (1999) 153-159
31. Williamson E.D., Flick-Smith H.C., Waters E.L., Miller J., Hodgson I., LeButt C.S., et al. Immunogenicity of the rF1 + rV vaccine for plague with identification of potential immune correlates. Microb Pathog 42 (2007) 11-21
32. Tito M.A., Miller J., Walker N., Griffin K.F., Williamson E.D., Despeyroux-Hill D., et al. Probing molecular interactions in intact antibody:antigen complexes, an electrospray time-of-flight mass spectrometry approach. Biophys J 81 (2001) 3503-3509
33. Broz P., Mueller C.A., Muller S.A., Philippsen I.S., Engel A., and Cornelis G.R. Function and molecular architecture of the Yersinia injectisome tip complex. Mol Microbiol 65 (2007) 1311-1320
34. Vernazza C., Lingard B., Flick-Smith H.C., Baillie L.W., Hill J., and Atkins H.S. Small protective fragments of the Yersinia pestis V antigen. Vaccine 27 (2009) 2775-2780